Serodiagnosis of pulmonary disease due to Mycobacterium avium complex proven by bronchial wash culture.

@article{Kitada2010SerodiagnosisOP,
  title={Serodiagnosis of pulmonary disease due to Mycobacterium avium complex proven by bronchial wash culture.},
  author={Seigo Kitada and Kazuo Kobayashi and Yukiko Nishiuchi and Kenji Fushitani and Kenji Yoshimura and Yoshitaka Tateishi and Keisuke Miki and Mari Miki and Hisako Hashimoto and Masaharu Motone and Takeya Fujikawa and Toru Hiraga and Ryoji Maekura},
  journal={Chest},
  year={2010},
  volume={138 1},
  pages={
          236-7
        }
}
Affi liations: From the Department of Pharmacy (Drs Ogale and Sullivan), University of Washington; the Center for Management of Complex Chronic Care (Dr Lee), Edward Hines Jr VA Hospital; and the Center for Pharmacoeconomic Research, Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL. Dr Ogale is currently at Genentech, Inc. Financial nonfi nancial disclosures: The authors have reported to CHEST the following confl icts of interest: Dr Ogale is an employee of… 

Tables from this paper

Serodiagnosis of Mycobacterium avium complex disease in humans: translational research from basic mycobacteriology to clinical medicine.

  • Kazuo Kobayashi
  • Medicine, Biology
    Japanese journal of infectious diseases
  • 2014
TLDR
This review discusses development of serodiagnosis of MAC-PD by translational research and international collaboration study, and demonstrates the usefulness of aserodiagnostic test to determine serum IgA antibodies against mycobacterial glycopeptidolipid (GPL) core antigen within a few hours.

Association of serum antibodies against the Mycobacterium avium complex and hemoptysis: a cross-sectional study

TLDR
Measuring the MAC-Ab may contribute not only to early detection of the risk of hemoptysis but also to early intervention with anti-NTM therapy and, as a result, to the prevention of hemiptysis in MAC patients.

The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody

TLDR
ThePositivity of a serum anti-glycopeptidolipid (GPL)-core IgA antibody test has an excellent diagnostic ability among patients with radiologically suspected Mycobacterium avium complex (MAC)-PD or Myc Cobacterium abscessus (MAB)-PD who already had a single positive sputum culture test.

Chapter 8 Nontuberculous mycobacterial infections

TLDR
Clinicians must evaluate clinical, radiographic and microbiologic information in order to diagnosis NTM-related lung disease, and diagnostic criteria cannot account for all clinical scenarios or for all NTM species given the large spectrum of pathogenicity encountered.

Nontuberculous Mycobacterial Infections

TLDR
Clinicians must evaluate clinical, radiographic and microbiologic information in order to diagnosis NTM-related lung disease, and diagnostic criteria cannot account for all clinical scenarios or for all NTM species given the large spectrum of pathogenicity encountered.

Infections with Nontuberculous Mycobacteria: Increased Awareness and Recent Developments

  • A. LewinH. Schäfer
  • Medicine, Biology
    Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions
  • 2019
TLDR
Higher priority for NTM disease both in basic research and when deciding on public health measures is indicated because of new findings on infection rates, transmission routes, and nosocomial potential of NTM.

Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report.

TLDR
Age, chronic alcoholism, previous professional exposure, tobacco smoking, chronic obstructive pulmonary disease and previous tuberculosis are found as risk factors for NTM disease in the HIV-negative patient.

An Accuracy-Based Approach to the Microbiologic Diagnosis of Pulmonary Infection

TLDR
The accuracy of any single diagnostic test for pneumonia is generally inadequate to rule out a pathogen, and empiric treatment should be considered when there is clinical suspicion despite negative testing.

Serodiagnosis of Mycobacterium avium Complex and Mycobacterium abscessus Complex Pulmonary Disease by Use of IgA Antibodies to Glycopeptidolipid Core Antigen

ABSTRACT An enzyme immunoassay kit that detects serum IgA antibody reacting to glycopeptidolipid core antigen derived from Mycobacterium avium complex (MAC) was not useful for differentiating MAC

References

SHOWING 1-9 OF 9 REFERENCES

Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit.

TLDR
The EIA kit is useful for the rapid diagnosis of Mycobacterium avium-complex pulmonary disease and for differentiating MAC-PD from pulmonary TB and, if validated by studies in other populations, could find wide application in clinical practice.

Serodiagnosis of pulmonary disease due to Mycobacterium avium complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid antigens.

  • S. KitadaR. Maekura Kazuo Kobayashi
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2002
TLDR
An enzyme immunoassay (EIA) for diagnosis of MAC pulmonary diseases that uses glycopeptidolipid (GPL) antigens specific for MAC, and it is used for diagnosis in immunocompetent patients.

Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease

TLDR
The present results document that the levels of immunoglobulin A antibody against glycopeptidolipid core correlate with the chest computed tomography findings of Mycobacterium avium complex lung disease.

Use of Glycopeptidolipid Core Antigen for Serodiagnosis of Mycobacterium avium Complex Pulmonary Disease in Immunocompetent Patients

TLDR
A serodiagnostic method for Mycobacterium avium complex (MAC) disease with an enzyme immunoassay (EIA) with the MAC-specific glycopeptidolipid (GPL) core as the antigen confirmed that the GPL core antibody was in the sera of immunocompetent patients with MAC disease.

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Diagnostic Criteria of Nontuberculous Mycobacterial Lung Disease Key Laboratory Features of NTM Health Careand Hygiene-associated Disease Prevention Prophylaxis and Treatment of NTM Disease

Cardiovascular events associated with ipratropium bromide in COPD.

TLDR
A cohort study of 82,717 US veterans with a new diagnosis of COPD found an increased risk of CVEs associated with the use of ipratropium bromide within the past 6 months, consistent with previous concerns raised about the cardiovascular safety of ipRatropium Bromide.

Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction.

TLDR
Patients who had filled a beta-agonist prescription had an increased risk of experiencing an acute coronary syndrome and a prescription for inhaled beta-agonists may increase the risk of myocardial infarction and unstable angina in patients with COPD.

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

BACKGROUND beta-Adrenergic agonists exert physiologic effects that are the opposite of those of beta-blockers. beta-Blockers are known to reduce morbidity and mortality in patients with cardiac